| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |